<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A cohort of 2122 US <z:chebi fb="4" ids="17642">pentachlorophenol</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>) production workers from four plants in the National Institute for Occupational Safety and Health <z:chebi fb="44" ids="28119">Dioxin</z:chebi> Registry was exposed to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> and to polychlorinated dibenzo-p-<z:chebi fb="44" ids="28119">dioxin</z:chebi> and <z:chebi fb="0" ids="28145">dibenzofuran</z:chebi> contaminants of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> production </plain></SENT>
<SENT sid="1" pm="."><plain>A subcohort of 720 was also exposed to 2,3,7,8-tetrachlorodibenzodioxin, a contaminant of trichlorophenol (TCP) while using TCP or a TCP derivative </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> and several production contaminants have been implicated as animal carcinogens </plain></SENT>
<SENT sid="3" pm="."><plain>A priori hypotheses were that the cohort would have elevated standardized mortality ratios (SMRs) for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, soft-tissue <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, and non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, as suggested by human studies, and for <z:hpo ids='HP_0001909'>leukemia</z:hpo> and liver, adrenal, thyroid, and <z:hpo ids='HP_0006780'>parathyroid cancer</z:hpo>, as suggested by animal studies </plain></SENT>
<SENT sid="4" pm="."><plain>From 1940 to 2005 1165 <z:hpo ids='HP_0011420'>deaths</z:hpo> occurred with an overall SMR of 1.01 [95% confidence limits (CI), 0.95-1.07] </plain></SENT>
<SENT sid="5" pm="."><plain>Overall <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality (326 <z:hpo ids='HP_0011420'>deaths</z:hpo>, SMR 1.17, CI 1.05-1.31) was in statistically significant excess </plain></SENT>
<SENT sid="6" pm="."><plain>There were excess <z:hpo ids='HP_0011420'>deaths</z:hpo> for trachea, bronchus and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancers</z:e> (126 <z:hpo ids='HP_0011420'>deaths</z:hpo>, SMR 1.36, CI 1.13-1.62), non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (17 <z:hpo ids='HP_0011420'>deaths</z:hpo>, SMR 1.77, CI 1.03-2.84), <z:hpo ids='HP_0006510'>chronic obstructive pulmonary disease</z:hpo> (63 <z:hpo ids='HP_0011420'>deaths</z:hpo>, SMR 1.38, CI 1.06-1.77), and medical complications (5 <z:hpo ids='HP_0011420'>deaths</z:hpo>, SMR 3.52, CI 1.14-8.22) </plain></SENT>
<SENT sid="7" pm="."><plain>In race- and sex-specific analyses, white males had increased non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> mortality (17 <z:hpo ids='HP_0011420'>deaths</z:hpo>, SMR 1.98, CI 1.15-3.17) and males of other races had increased <z:hpo ids='HP_0001909'>leukemia</z:hpo> mortality (four <z:hpo ids='HP_0011420'>deaths</z:hpo>, SMR 4.57, CI 1.25-11.7) </plain></SENT>
<SENT sid="8" pm="."><plain>The excess of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> of a priori interest, non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0001909'>leukemia</z:hpo>, provide some support for the <z:e sem="disease" ids="C0858970" disease_type="Neoplastic Process" abbrv="">carcinogenicity</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>, however, further studies with more detailed exposure assessment are needed </plain></SENT>
</text></document>